장호충 (성균관대학교)님 | 한빛사연구자 > 한빛사

성균관대학교

최종업데이트 2025.09.26.

Oral PTP1B siRNA Delivery Using Milk-Derived Extracellular Vesicles for Alleviation of Acute Kidney Injury
- ACS Nano, Nov 17 2025, | https://doi.org/10.1021/acsnano.5c15067
- 2025-11
- 바이오·의료융합
- 한빛사논문
Repurposing mesalamine for acute kidney injury through supramolecular assembly
- J. Control. Release, Available online 17 July 2025, 114041 | https://doi.org/10.1016/j.jconrel.2025.114041
- 2025-07
- 바이오·의료융합
- 한빛사논문
Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs
- Theranostics, Published 2024-8-26;14(14):5413-5428 | doi:10.7150/thno.97269
- 2024-08
- 바이오·의료융합
- 한빛사논문
Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery
- Biomater. Res., Nov 29 2023, 27 (1) | https://doi.org/10.1186/s40824-023-00456-w
- 2023-11
- 바이오·의료융합
- 한빛사논문
Immune checkpoint-targeted drug conjugates: A promising tool for remodeling tumor immune microenvironment
- J. Control. Release, Available online 2 June 2023 | https://doi.org/10.1016/j.jconrel.2023.05.031
- 2023-06
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문